BNP Paribas Financial Markets’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12
| Closed | -$83 | – | 4208 |
|
|
2022
Q3 | $83 | Hold |
12
| – | – | ﹤0.01% | 3942 |
|
|
2022
Q2 | $132 | Hold |
12
| – | – | ﹤0.01% | 3371 |
|
|
2022
Q1 | $274 | Sell |
12
-4
| -25% | -$91 | ﹤0.01% | 3496 |
|
|
2021
Q4 | $457 | Sell |
16
-2
| -11% | -$57 | ﹤0.01% | 3467 |
|
|
2021
Q3 | $1.18K | Hold |
18
| – | – | ﹤0.01% | 3255 |
|
|
2021
Q2 | $1.44K | Sell |
18
-65
| -78% | -$5.19K | ﹤0.01% | 3312 |
|
|
2021
Q1 | $11.1K | Sell |
83
-45
| -35% | -$6.01K | ﹤0.01% | 3253 |
|
|
2020
Q4 | $20.4K | Sell |
128
-34
| -21% | -$5.42K | ﹤0.01% | 3187 |
|
|
2020
Q3 | $17K | Buy |
162
+114
| +238% | +$12K | ﹤0.01% | 3250 |
|
|
2020
Q2 | $5.76K | Sell |
48
-147
| -75% | -$17.6K | ﹤0.01% | 3317 |
|
|
2020
Q1 | $15.3K | Buy |
195
+94
| +93% | +$7.37K | ﹤0.01% | 3350 |
|
|
2019
Q4 | $29.6K | Buy |
101
+10
| +11% | +$2.93K | ﹤0.01% | 3220 |
|
|
2019
Q3 | $16.4K | Buy |
91
+28
| +44% | +$5.04K | ﹤0.01% | 3396 |
|
|
2019
Q2 | $25.1K | Sell |
63
-54
| -46% | -$21.5K | ﹤0.01% | 3193 |
|
|
2019
Q1 | $54.6K | Buy |
+117
| New | +$54.6K | ﹤0.01% | 2865 |
|
|
2018
Q4 | – | Sell |
-18
| Closed | -$12K | – | 3747 |
|
|
2018
Q3 | $12K | Hold |
18
| – | – | ﹤0.01% | 2981 |
|
|
2018
Q2 | $12K | Buy |
+18
| New | +$12K | ﹤0.01% | 3053 |
|